Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Risedronate Sodium Tablets

Approval Number

国药准字H20040391

Company常州华生制药有限公司

Registration Date

August 17, 2020

Previous Approval Numbers

国药准字H20040391

Drug Information

Generic Name

利塞膦酸钠片

Trade Name

吉威

Dosage Form

片剂

Strength

5mg(按C7H10NO7P2Na计)

Drug Type

化学药品

Registration Date

August 17, 2020

Company Information

Applicant Company

Company Name常州华生制药有限公司

Manufacturing Company

Company Name常州华生制药有限公司

Company Address

江苏省常州市新北区河海路98号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy